Standard Biotools Inc. (LAB)
NASDAQ · Healthcare
Standard Biotools Inc. Revenue 2009–2025
Standard Biotools Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Standard Biotools Inc. revenue for the quarter ending March 31, 2026 was 21.1 M, a 4.57% increase year-over-year.
- Standard Biotools Inc. revenue for the twelve months ending March 31, 2026 was 82.7 M, a 28.40% decrease year-over-year.
- Standard Biotools Inc. annual revenue for 2025 was 85.3 M, a 6.24% decrease from 2024.
- Standard Biotools Inc. annual revenue for 2024 was 91.0 M, a 14.42% decrease from 2023.
- Standard Biotools Inc. annual revenue for 2023 was 106.3 M, a 8.57% increase from 2022.
- Standard Biotools Inc. annual revenue for 2022 was 97.9 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Standard Biotools Inc. Revenue — FAQ
Standard Biotools Inc. (LAB) revenue over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Standard Biotools Inc.'s revenue?
Standard Biotools Inc. (LAB) reported revenue of $85M for fiscal 2025.
Where can I see LAB's revenue history?
The chart and table above show Standard Biotools Inc.'s revenue by year and by quarter, including the growth rate.